Effectiveness, efficiency, and NICE - A NICE start but evidence costs money

被引:30
作者
Sculpher, M [1 ]
Drummond, M
O'Brien, B
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
来源
BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7292期
关键词
D O I
10.1136/bmj.322.7292.943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:943 / 944
页数:2
相关论文
共 8 条
[1]  
Commonwealth Australia, 1995, GUID PHARM IND PREP
[2]   Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme [J].
Hill, SR ;
Mitchell, AS ;
Henry, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16) :2116-2121
[3]  
*MIN HLTH, 1994, ONT GUID EC AN PHARM
[4]  
*NAT I CLIN EXC, 2001, TECHN APPR WORK PROG
[5]  
*NAT I CLIN EXC, 1999, ZAN REL GUID NICE
[6]  
*NAT I CLIN EXC, 1999, APPR NEW EX TECHN IN
[7]  
*NAT I CLIN EXC, 2001, US ZAN REL TREATM IN
[8]  
*NAT I CLIN EXC, 2001, TECHN APPR PROGR NEW